330 related articles for article (PubMed ID: 9088851)
1. What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose.
Yan SD; Stern D; Schmidt AM
Eur J Clin Invest; 1997 Mar; 27(3):179-81. PubMed ID: 9088851
[No Abstract] [Full Text] [Related]
2. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
3. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
Schmidt AM; Yan SD; Wautier JL; Stern D
Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
[TBL] [Abstract][Full Text] [Related]
4. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
Stern DM; Yan SD; Yan SF; Schmidt AM
Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
[TBL] [Abstract][Full Text] [Related]
5. The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications.
Yan SF; Barile GR; D'Agati V; Du Yan S; Ramasamy R; Schmidt AM
Curr Diab Rep; 2007 Apr; 7(2):146-53. PubMed ID: 17425919
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.
Sasaki N; Toki S; Chowei H; Saito T; Nakano N; Hayashi Y; Takeuchi M; Makita Z
Brain Res; 2001 Jan; 888(2):256-262. PubMed ID: 11150482
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease: what's all the AGE/RAGE about?
Barlovic DP; Thomas MC; Jandeleit-Dahm K
Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):7-15. PubMed ID: 20041839
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in advanced glycation end products and diabetic complications.
Vlassara H
Diabetes; 1997 Sep; 46 Suppl 2():S19-25. PubMed ID: 9285494
[No Abstract] [Full Text] [Related]
9. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
Yan SF; Ramasamy R; Schmidt AM
J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
[TBL] [Abstract][Full Text] [Related]
10. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation endproducts in diabetes and diabetic complications.
Vlassara H; Striker GE
Endocrinol Metab Clin North Am; 2013 Dec; 42(4):697-719. PubMed ID: 24286947
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products and insulin resistance.
Unoki H; Yamagishi S
Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy.
Yamagishi S; Nakamura K; Matsui T
Curr Drug Discov Technol; 2006 Mar; 3(1):83-8. PubMed ID: 16712466
[TBL] [Abstract][Full Text] [Related]
15. Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.
Wendt T; Tanji N; Guo J; Hudson BI; Bierhaus A; Ramasamy R; Arnold B; Nawroth PP; Yan SF; D'Agati V; Schmidt AM
J Am Soc Nephrol; 2003 May; 14(5):1383-95. PubMed ID: 12707408
[TBL] [Abstract][Full Text] [Related]
16. The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.
Ramasamy R; Yan SF; Schmidt AM
Vascul Pharmacol; 2012; 57(5-6):160-7. PubMed ID: 22750165
[TBL] [Abstract][Full Text] [Related]
17. RAGE: a novel target for drug intervention in diabetic vascular disease.
Hudson BI; Schmidt AM
Pharm Res; 2004 Jul; 21(7):1079-86. PubMed ID: 15290845
[TBL] [Abstract][Full Text] [Related]
18. Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.
Carnevale D; Mascio G; D'Andrea I; Fardella V; Bell RD; Branchi I; Pallante F; Zlokovic B; Yan SS; Lembo G
Hypertension; 2012 Jul; 60(1):188-97. PubMed ID: 22615109
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation endproducts and their receptor: do they play a role in diabetic cardiomyopathy?
Arai M
J Mol Cell Cardiol; 2002 Oct; 34(10):1305-8. PubMed ID: 12392990
[No Abstract] [Full Text] [Related]
20. Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.
Hudson BI; Bucciarelli LG; Wendt T; Sakaguchi T; Lalla E; Qu W; Lu Y; Lee L; Stern DM; Naka Y; Ramasamy R; Yan SD; Yan SF; D'Agati V; Schmidt AM
Arch Biochem Biophys; 2003 Nov; 419(1):80-8. PubMed ID: 14568011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
